General MedicationsINJECTIONGeneric
CYANOKIT
HYDROXOCOBALAMIN
Standard Dose
2.5GM/VIAL (5GM/KIT)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview CYANOKIT is listed in Drugs@FDA under application 022041 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROXOCOBALAMIN Form and strength INJECTABLE;INJECTION - 2.5GM/VIAL (5GM/KIT) Sponsor BTG INTL Submission history Latest submission status date: 2018-12-31 00:00:00.
Structured Monograph
Clinical summary
Approval overview CYANOKIT is listed in Drugs@FDA under application 022041 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROXOCOBALAMIN Form and strength INJECTABLE;INJECTION - 2.5GM/VIAL (5GM/KIT) Sponsor BTG INTL Submission history Latest submission status date: 2018-12-31 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.